Identification of an antivirulence agent targeting the master regulator of virulence genes in Staphylococcus aureus
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1268044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Rekha Arya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision Medicine, Sungkyunkwan University School of Medicine, Institute of Antibacterial Resistance Research and Therapeutics, Suwon,…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
The emergence of bactericidal antibiotic-resistant strains has increased the demand for alternative therapeutic agents, such as antivirulence agents targeting the virulence regulators of pathogens. Staphylococcus aureus exoprotein expression ( sae ) locus, the master regulator of virulence gene expression in multiple drug-resistant S. aureus , is a promising therapeutic target. In this study, we screened a small-molecule library using a SaeRS green fluorescent protein (GFP)-reporter that responded to transcription controlled by the sae locus. We identified the compound, N-(2-methylcyclohexyl)-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide (SKKUCS), as an efficient repressor of sae -regulated GFP activity. SKKUCS inhibited hemolysin production and reduced α-hemolysin-mediated cell lysis. Moreover, SKKUCS substantially reduced the expression levels of various virulence genes controlled by the master regulators, sae , and the accessory gene regulator ( agr ), demonstrating its potential as an antivirulence reagent targeting the key virulence regulators. Furthermore, autokinase inhibition assay and molecular docking suggest that SKKUCS inhibits the kinase activity of SaeS and potentially targets the active site of SaeS kinase, possibly inhibiting ATP binding. Next, we evaluated the efficacy and toxicity of SKKUCS in vivo using murine models of staphylococcal intraperitoneal and skin infections. Treatment with SKKUCS markedly increased animal survival and significantly decreased the bacterial burden in organs and skin lesion sizes. These findings highlight SKKUCS as a potential antivirulence drug for drug-resistant staphylococcal infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Precision Medicine, Sungkyunkwan University School of Medicine, Institute of Antibacterial Resistance Research and Therapeutics, Suwon, Republic of Korea.
- Department of Orthopedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
- Department of Microbiology and Immunology, Indiana University School of Medicine-Northwest, Gary, IN, United States.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Arya, R., Kim, T., Youn, J. W., Bae, T., & Kim, K. K. (2023). Identification of an antivirulence agent targeting the master regulator of virulence genes in Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1268044
Vancouver
Arya R, Kim T, Youn JW, Bae T, Kim KK. Identification of an antivirulence agent targeting the master regulator of virulence genes in Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1268044
BibTeX
@article{Arya2023,
author = {Arya, Rekha and Kim, Truc and Youn, Joo Won and Bae, Taeok and Kim, Kyeong Kyu},
title = {Identification of an antivirulence agent targeting the master regulator of virulence genes in Staphylococcus aureus},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1268044}
}
EUVIMED